Search Ontology:
ChEBI
daclatasvir
- Term ID
- CHEBI:82977
- Synonyms
-
- BMS 790052
- BMS-790052
- BMS790052
- Dimethyl N,N'-(biphenyl-4,4'-diylbis{1H-imidazole-5,2-diyl-((2S)-pyrrolidine-2,1- diyl)((1S)-1-(1-methylethyl)-2-oxoethane-2,1-diyl)})dicarbamate
- methyl [(2S)-1-{(2S)-2-[4-(4'-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl]-1H-imidazol-4-yl}biphenyl-4-yl)-1H-imidazol-2-yl]pyrrolidin-1-yl}-3-methyl-1-oxobutan-2-yl]carbamate
- Definition
- A member of the class of biphenyls that is a potent inhibitor of nonstructural protein 5A and is used (as its hydrochloride salt) for treatment of hepatitis C.
- References
-
- CAS:1009119-64-5
- Drug_Central:4875
- KEGG:D10065
- PMID:23089758
- PMID:23177287
- PMID:23403428
- PMID:23431163
- PMID:23684844
- PMID:23931586
- PMID:24169581
- PMID:24343001
- PMID:24372205
- PMID:24448487
- PMID:24451122
- PMID:24451151
- PMID:24612030
- PMID:24623983
- PMID:25080450
- PMID:25117173
- PMID:25117197
- PMID:25311593
- PMID:25365735
- Reaxys:13077731
- Wikipedia:Daclatasvir
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
- inverse is_conjugate_acid_of
-
- is_conjugate_base_of
-
Phenotype
Phenotype resulting from daclatasvir
Phenotype where environments contain daclatasvir
Phenotype modified by environments containing daclatasvir
Human Disease Model